L-carnitine and COH in PCOS Women Undergoing IVF/ICSI Cycles

NCT ID: NCT04672720 Phase: NA Status: COMPLETED Enrollment: 110 Completion: 2023-02-28

Conditions

Polycystic Ovary Syndrome

Interventions

L-carnitine 1000 Mg

Summary

The aim of this study was to evaluate the effect of oral L-carnitine supplementation during controlled ovarian stimulation (COS) in patients with polycystic ovary syndrome (PCOS) in a double-blind randomized clinical trial. The eligible patients with PCOS diagnosis (on the basis of Rotterdam criteria) who referred to Royan Research Institute for IVF / ICSI treatment cycles will be evaluated.

Primary Outcome

Occyte maturity rate

Source

ClinicalTrials.gov